Fed Raises Discount Rate 0.75 Percentage Points To 1.75%

Tickers to watch following Fed decision: SPDR S&P 500 (NYSE: SPY) SPDR Gold Trust (NYSE: GLD) Invesco QQQ Trust, Series 1 (NASDAQ: QQQ)

byBill Haddad

June 15, 2022

1 minute read

Tickers to watch following Fed decision:

SPDR S&P 500 (NYSE:SPY)
SPDR Gold Trust (NYSE:GLD)
Invesco QQQ Trust, Series 1 (NASDAQ:QQQ)

Tickers to watch following Fed decision:

SPDR S&P 500 (NYSE:SPY)
SPDR Gold Trust (NYSE:GLD)
Invesco QQQ Trust, Series 1 (NASDAQ:QQQ)

Looking At CrowdStrike Holdings’s Recent Whale Trades

By Benzinga Insights

Today, 10:12 PM

A whale with a lot of money to spend has taken a noticeably bearish stance on CrowdStrike Holdings. Looking at options history for CrowdStrike Holdings (NASDAQ:CRWD) we detected 35 strange trades.

CRWD

Cryptocurrency Solana Up More Than 9% In 24 hours

By Benzinga Insights

Today, 10:12 PM

Over the past 24 hours, Solana's (CRYPTO: SOL) price has risen 9.84% to $208.9. This continues its positive trend over the past week where it has experienced a 30.0% gain, moving from $159.8 to its current price. As it stands right now, the coin's all-time high is $213.47.

SOL

Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back

By Jelena Martinovic

Today, 10:12 PM

Cannabis investors are in the midst of earnings season, which is also a timely opportunity to take a glimpse at the stock performance of some big players within the space.

ACB

AI Study: Synthetic Cannabinoid + Favipiravir Presents Viable Treatment Against Viral Infections, Including COVID

By Vuk Zdinjak

Today, 10:12 PM

Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1), announced results from the study of Onternabez combined with Favipiravir against ARDS (acute respiratory distress syndrome), sepsis, and COVID-19 through PREPAiRE, an AI

TBPMF

Fed Raises Discount Rate 0.75 Percentage Points To 1.75%

Related Posts

Looking At CrowdStrike Holdings’s Recent Whale Trades

Cryptocurrency Solana Up More Than 9% In 24 hours

Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back

AI Study: Synthetic Cannabinoid + Favipiravir Presents Viable Treatment Against Viral Infections, Including COVID